Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5658552 | Gastroenterology | 2017 | 21 Pages |
Abstract
For treatment-naïve and -experienced patients, ledipasvir-sofosbuvir for 12 weeks is highly effective for the treatment of HCV genotype 2 (ClinicalTrials.gov: NCT02202980).
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Edward J. Gane, Robert H. Hyland, Yin Yang, Evguenia Svarovskaia, Luisa M. Stamm, Diana M. Brainard, John G. McHutchison, Catherine A.M. Stedman,